Company Filing History:
Years Active: 2008
Title: Yodhathai Thebtaranonth: Innovator in Antituberculosis Compounds
Introduction
Yodhathai Thebtaranonth is a prominent inventor based in Pathumthani, Thailand. With a focus on the development of novel pharmaceutical compounds, he has made significant contributions to the fields of biotechnology and medicine. His dedication to research is exemplified in his patent for antituberculosis compounds, particularly through his work involving unique alkaloids derived from fungal cultures.
Latest Patents
Thebtaranonth holds a patent for three new alkaloids known as Hirsutellones A, B, and C. These compounds are produced in cultures of fungi, specifically strain BCC 2594 and sp. strain BCC 7579. The Hirsutellones display impressive growth inhibitory activity against the H37Ra strain of tuberculosis, with a minimum inhibitory concentration (MIC) value of 0.78 µg/ml. Importantly, these compounds exhibit weak or no cytotoxicity to mammalian cells, suggesting their potential as safe therapeutic options for treating tuberculosis. The patent also describes methods for isolating the Hirsutellones, further enhancing their applicability in pharmaceutical development.
Career Highlights
Thebtaranonth is affiliated with the National Center for Genetic Engineering and Biotechnology, which is part of the National Science and Technology Development Agency in Thailand. His work in this esteemed organization has allowed him to explore innovative approaches to tackling significant health challenges, including infectious diseases like tuberculosis.
Collaborations
Throughout his career, Thebtaranonth has collaborated with other notable researchers, including Masahiko Isaka and Nigel Leslie Hywel-Jones. These partnerships have enriched his research endeavors, fostering an environment of creativity and collaboration that is vital for scientific advancements.
Conclusion
Yodhathai Thebtaranonth's contributions to the development of antituberculosis compounds showcase his commitment to innovation and public health. With his unique findings on Hirsutellones A, B, and C, he remains an influential figure in the realms of biotechnology and pharmaceuticals, paving the way for new treatments that could benefit countless individuals suffering from tuberculosis.